Venus Remedies secures award for antibiotic product Ceftriaxone 1gm from UNICEF

13 Jun 2024 Evaluate

Venus Remedies has reached a significant milestone by securing the prestigious award for its antibiotic product, Ceftriaxone 1gm, from UNICEF in the Beta Lactam tender. This recognition follows the earlier achievement of receiving GMP (Good Manufacturing Practices) approval from UNICEF, which underscores its commitment to maintaining exceptional quality standards.

UNICEF's decision to award the tender to Venus Remedies is a testament to its relentless pursuit of excellence in healthcare. Its Ceftriaxone 1gm product has met and surpassed stringent quality criteria, demonstrating its dedication to producing top-tier pharmaceutical solutions. This award not only highlights its product's superior quality but also reinforces its role as a trusted partner in global health initiatives. 

Venus Remedies will continue to uphold the highest standards of quality and commitment, ensuring that its products contribute significantly to the well-being of communities around the globe and remain dedicated to its mission of advancing global health through innovation and excellence in the pharmaceutical industry. 

Venus Remedies is one of the handful player in pharmaceutical sector to launch world global injectable manufacturers.


Venus Remedies Share Price

785.35 -7.25 (-0.91%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×